2. Academic Validation
  3. Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir

Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir

  • Signal Transduct Target Ther. 2021 Feb 4;6(1):51. doi: 10.1038/s41392-021-00468-9.
Yu Bai  # 1 2,  Fei Ye  # 3,  Yong Feng  # 1 2,  Hanyi Liao 1 2,  Hao Song 4,  Jianxun Qi 1 2,  George Fu Gao 1 2 5,  Wenjie Tan 6,  Lifeng Fu 7 8,  Yi Shi 9 10 11
Affiliations

Affiliations

  • 1 Savaid Medical School, University of Chinese Academy of Sciences, Beijing, 100049, China.
  • 2 CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
  • 3 NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control and Prevention, China CDC, Beijing, 102206, China.
  • 4 Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, 100101, China.
  • 5 Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Disease (CEEID), Chinese Academy of Sciences, Beijing, 100101, China.
  • 6 Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, 100101, China. [email protected].
  • 7 CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China. [email protected].
  • 8 Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Disease (CEEID), Chinese Academy of Sciences, Beijing, 100101, China. [email protected].
  • 9 Savaid Medical School, University of Chinese Academy of Sciences, Beijing, 100049, China. [email protected].
  • 10 CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China. [email protected].
  • 11 Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Disease (CEEID), Chinese Academy of Sciences, Beijing, 100101, China. [email protected].
  • # Contributed equally.
PMID: 33542181 DOI: 10.1038/s41392-021-00468-9
Figures
Products